Biosignatures of Health Status

Stephen Johnston (Inventor)

Research output: Patent

Abstract

Diagnosis today is largely based on single timepoint measurement of a few elements that are normalized against a population. The principle disclosed here is the measurement of many elements at once, self normalization of signals, realtime measurement and ability to determine disease pre-symptomatically.Such a technology would revolutionize diagnosis.A key claim would be self normalizationA key claim may be the number of ligands on the chip to measure fluid levelsA key element may be the specific ligands on the chip.
Original languageEnglish (US)
StatePublished - Jun 2 2006

Fingerprint

Health Status
Ligands
Technology
Population

Cite this

@misc{42628a927f8c4b6c9068a5ffc310c9ca,
title = "Biosignatures of Health Status",
abstract = "Diagnosis today is largely based on single timepoint measurement of a few elements that are normalized against a population. The principle disclosed here is the measurement of many elements at once, self normalization of signals, realtime measurement and ability to determine disease pre-symptomatically.Such a technology would revolutionize diagnosis.A key claim would be self normalizationA key claim may be the number of ligands on the chip to measure fluid levelsA key element may be the specific ligands on the chip.",
author = "Stephen Johnston",
year = "2006",
month = "6",
day = "2",
language = "English (US)",
type = "Patent",

}

TY - PAT

T1 - Biosignatures of Health Status

AU - Johnston, Stephen

PY - 2006/6/2

Y1 - 2006/6/2

N2 - Diagnosis today is largely based on single timepoint measurement of a few elements that are normalized against a population. The principle disclosed here is the measurement of many elements at once, self normalization of signals, realtime measurement and ability to determine disease pre-symptomatically.Such a technology would revolutionize diagnosis.A key claim would be self normalizationA key claim may be the number of ligands on the chip to measure fluid levelsA key element may be the specific ligands on the chip.

AB - Diagnosis today is largely based on single timepoint measurement of a few elements that are normalized against a population. The principle disclosed here is the measurement of many elements at once, self normalization of signals, realtime measurement and ability to determine disease pre-symptomatically.Such a technology would revolutionize diagnosis.A key claim would be self normalizationA key claim may be the number of ligands on the chip to measure fluid levelsA key element may be the specific ligands on the chip.

M3 - Patent

ER -